Source link : https://www.newshealth.biz/health-news/long-acting-fluticasone-propionate-offers-hope-in-knee-oa/
TOPLINE: The extended-release fluticasone propionate injection (EP-104IAR) significantly reduces knee osteoarthritis (OA) pain over 12 weeks compared with a vehicle control, with no serious treatment-related adverse events. METHODOLOGY: EP-104IAR utilizes a novel diffusion-based extended-release technology to optimize the action of fluticasone propionate. The researchers conducted a phase 2 trial at 12 research sites in Denmark, […]
Author : News Health
Publish date : 2024-10-28 11:17:08
Copyright for syndicated content belongs to the linked Source.
inHealth